Evidence map›Paper›PMID 29059147›Full record

ReviewDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]2018

Atypical Melanocytic Proliferations: A Review of the Literature.

Courtney J Ensslin, Brian P Hibler, Erica H Lee, Kishwer S Nehal, Klaus J Busam, Anthony M Rossi

Abstract readReview
In one paragraph

Review in Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Response to Rigel et al.The Journal of investigative dermatology · 2022
    Article
  12. Observational
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Courtney J EnsslinDepartment of Dermatology, Johns Hopkins University, Baltimore, Maryland.
Brian P HiblerDepartment of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Erica H LeeDepartment of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Kishwer S NehalDepartment of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Klaus J BusamDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Anthony M RossiDepartment of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundAmbiguous histopathologic diagnoses represent a challenge for clinicians because of a lack of definitive diagnosis and related uncertainty about management.

objectiveTo review the literature on atypical melanocytic proliferations and detail synonymous terms, epidemiology, diagnostic work-up, histopathology, treatment, and prognosis.

methodsDatabases from PubMed and Web of Science were searched for articles related to atypical melanocytic proliferations.

resultsIntraepidermal melanocytic proliferations with features worrisome for possible melanoma in situ (MIS) are generally excised as for MIS. Reported rates of upstaging of such cases to invasive melanoma on review of the excision are very low. Because invasion, lymph node spread, and metastasis can occur in atypical melanocytic lesions with a thick intradermal component, these are often treated as for malignant melanoma.

conclusionBecause the diagnosis dictates treatment, it is incumbent to establish a diagnosis as definitive as possible, obtaining second or third opinions and using ancillary studies when appropriate. When the diagnosis remains uncertain, it is difficult to provide guidelines for treatment. Clinical care decisions for patients with an uncertain diagnosis are best done on a case-by-case basis weighing probabilities of adverse outcomes against potential benefits and risks from various treatment options.

Indexed as

Diagnosis, DifferentialHumansMelanomaPrecancerous ConditionsSkin Neoplasms

Identifiers

PMID29059147
PMCPMC6639034

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.